Portal Hypertension Related to Cirrhosis Clinical Trials

9 recruiting

Frequently Asked Questions

Common questions about Portal Hypertension Related to Cirrhosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

Indicators Affecting PVT Recanalization

CirrhosisPortal Hypertension Related to CirrhosisPortal Vein Thrombosis+1 more
Shanghai Zhongshan Hospital1,500 enrolled1 locationNCT07473375
Recruiting
Phase 4

Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease

Portal Hypertension Related to CirrhosisLiver CirrhosesTIPS+1 more
The Cleveland Clinic70 enrolled1 locationNCT07058155
Recruiting

A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis

MRIUltrasoundHepatocellular Carcinoma (HCC)+3 more
Mattias Ekstedt600 enrolled1 locationNCT07291141
Recruiting
Not Applicable

Effectiveness and Safety of TIPS Stent Graft in the Treatment of Cirrhosis and Complications of Portal Hypertension

Portal Hypertension Related to CirrhosisVariceal BleedingAscites Hepatic
C. R. Bard166 enrolled1 locationNCT06669806
Recruiting
Not Applicable

TIPS With or Without BCAA

SarcopeniaCirrhosisPortal Hypertension Related to Cirrhosis+2 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology164 enrolled1 locationNCT07281846
Recruiting

2D-shear Wave Spleen Elastography in Clinically Significant Portal Hypertension and High-risk Varices

Portal Hypertension Related to CirrhosisEsophageal Varices
Fondazione Policlinico Universitario Agostino Gemelli IRCCS450 enrolled1 locationNCT07122622
Recruiting
Not Applicable

CARPEUS : Effect of Carvedilol on the Portosystemic Gradient as Measured by Endoscopic Ultrasound

CirrhosisPortal Hypertension Related to Cirrhosis
University Hospital, Clermont-Ferrand30 enrolled2 locationsNCT06861075
Recruiting
Phase 2

Effects of Metformin on Hepatic Venous Pressure Gradient in Patients With Cirrhosis and Portal Hypertension

CirrhosisPortal Hypertension Related to Cirrhosis
Assistance Publique - Hôpitaux de Paris76 enrolled1 locationNCT06687265
Recruiting
Not Applicable

EUS-guided Response Assessment to NSBB

Portal Hypertension Related to Cirrhosis
Universitaire Ziekenhuizen KU Leuven24 enrolled1 locationNCT06513195